FDA lawyer digs in her heels as Mak­e­na ac­cel­er­at­ed ap­proval with­draw­al saga drags on

It’s been al­most 18 months since the FDA rec­om­mend­ed that Co­vis Phar­ma with­draw its con­tro­ver­sial preterm birth drug Mak­e­na, and still the drug, which first …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA